XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 776.0 $ 717.4
Operating expenses:    
Salaries and benefits 238.6 215.2
Supplies 215.8 188.8
Professional and medical fees 95.3 82.6
Lease expense 20.8 21.4
Other operating expenses 43.6 54.1
Cost of revenues 614.1 562.1
General and administrative expenses 36.0 33.2
Depreciation and amortization 36.3 33.7
Transaction and integration costs 24.7 17.4
Net loss on disposals, consolidations and deconsolidations 6.4 1.5
Equity in earnings of unconsolidated affiliates (5.6) (2.7)
Litigation settlements 2.2 (1.8)
Other income, net 0.0 (2.0)
Total operating expenses 714.1 641.4
Operating income 61.9 76.0
Interest expense, net (62.2) (47.3)
(Loss) income before income taxes (0.3) 28.7
Income tax expense 0.0 (4.4)
Net (loss) income (0.3) 24.3
Less: Net income attributable to non-controlling interests (37.4) (36.7)
Net loss attributable to Surgery Partners, Inc. $ (37.7) $ (12.4)
Net loss per share attributable to common stockholders:    
Basic (in USD per share) $ (0.30) $ (0.10)
Diluted (in USD per share) [1] $ (0.30) $ (0.10)
Weighted average common shares outstanding:    
Basic (shares) 126,602 125,972
Diluted (shares) [1] 126,602 125,972
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.